Start with post-ROSC care, then use chronic kidney disease work-up and cancer staging to sharpen today's most practical diagnostic and follow-up decisions.
After ROSC, hunt shock and reversible causes before the next arrest.
Start with Post-ROSC Care. It is the most immediately useful listen today because it stays in the first hour after return of spontaneous circulation, when re-arrest, shock and missed reversible causes cluster together. The episode is practical: early invasive monitoring, push-dose vasopressors, pragmatic MAP targets, and a wide search with rainbow labs, toxicology and contrast pan-CT/CTA.
The rest of the list is mixed. Chronic kidney disease is the next best use of time because it turns a reduced eGFR or raised urine albumin:creatinine ratio into staging, cardiovascular risk reduction, ACE inhibitor and SGLT2 choices, and referral thresholds. Cancer offers a clear reset on invasion, metastasis and TNM staging, while the orthopaedic episode is a specialist but usable guide to painful periprosthetic femoral fracture non-union. The neurology training and TFP deficiency episodes are the more niche listens today. The habit to keep is simple: once ROSC is achieved or a reduced eGFR is flagged, move straight to formal risk assessment instead of stopping at the first abnormality.
Start here. The episode keeps the first 5-10 minutes after ROSC in view, where re-arrest and shock still shape outcome. Early invasive monitoring, push-dose vasopressors, pragmatic MAP targets, and a deliberate search with labs, toxicology and pan-CT/CTA make it the clearest practical listen of the day.
A reduced eGFR only becomes clinically useful when it is staged properly. This episode shows how urine albumin:creatinine ratio and chronicity turn abnormal bloods into chronic kidney disease risk, then links that stage to cardiovascular risk reduction, ACE inhibitor and SGLT2 choices, and referral thresholds.
If "cancer" has started to feel like one word for too many diseases, this is a helpful reset. The episode separates invasion from metastasis, carcinoma from sarcoma, and TNM staging from tumour biology, so site, histology and stage stay distinct in clinical thinking.
Useful for anyone who sees complex revision cases or recurrent falls. The teaching point is that painful non-union after plated periprosthetic fracture needs more than another fixation attempt: infection work-up, CT or CTA planning, bone quality, and distal fixation all drive the revision strategy.
Rare, but not just academic. The episode explains why triheptanoin reduces metabolic crises yet leaves retinopathy and neuropathy behind, then makes the case for elamipretide through cardiolipin remodelling and biomarker thinking.
When a patient gets ROSC, do not treat the next phase as routine monitoring. Use the first 5-10 minutes for invasive blood pressure, early vasopressor planning, and a structured search for reversible causes and post-resuscitation complications. If a low eGFR turns up in clinic, pair it with urine albumin:creatinine ratio and chronicity rather than writing "renal impairment" and moving on.
What belongs in the first 5-10 minutes after ROSC?
The first 5-10 minutes should focus on preventing re-arrest and shock. The episode pushes invasive blood pressure monitoring, push-dose vasopressors and pragmatic MAP targets into that early plan.
Why does the post-ROSC episode keep a broad diagnostic net?
Because cardiac arrest is treated as a final common pathway, not a diagnosis. Rainbow labs, toxicology and contrast pan-CT/CTA are used to look for the cause of arrest and complications of resuscitation.
What makes chronic kidney disease staging more useful than noting a low eGFR?
It combines eGFR with urine albumin:creatinine ratio and chronicity, so risk is described properly. That stage then drives cardiovascular risk reduction, ACE inhibitor and SGLT2 use, and referral thresholds.
.svg)